Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer

Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models

(2012) Shinichi Esaki et al.   INTERNATIONAL JOURNAL OF CANCER

Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice

(2011) Shinichi Esaki et al.   ACTA OTO-LARYNGOLOGICA

Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo

(2010) Shinichi Esaki et al.   ARCHIVES OF VIROLOGY

Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer

(2010) S Fujiwara et al.   CANCER GENE THERAPY

Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

(2010) K. J. Harrington et al.   CLINICAL CANCER RESEARCH

Convergent pathways of macrophage polarization: The role of B cells

(2010) Antonio Sica et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma

(2009) Howard L. Kaufman et al.   ANNALS OF SURGICAL ONCOLOGY

Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b+/CCR3−/Gr-1− cells cytotoxic against the tumor cells

(2009) Takeshi Takahashi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

(2009) Kathleen M. Schmeler et al.   GYNECOLOGIC ONCOLOGY

Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors

(2009) Maria R. Roche et al.   GYNECOLOGIC ONCOLOGY

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

(2009) Neil N. Senzer et al.   JOURNAL OF CLINICAL ONCOLOGY

Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10

(2008) Daisuke Watanabe et al.   JOURNAL OF DERMATOLOGICAL SCIENCE